Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore which regional ETF yields the highest and the factors behind regional performance. Understand implications for income-focused portfolios.
22,056 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
U.S. households are trimming credit-card balances as total debt hovers near $1.25 trillion, signaling a shift in cons...
The U.S. Treasury’s latest report signals a nuanced path for crypto privacy within regulated markets, hinting at supe...
A surprise drop in June inflation is pushing investors to question a July rate hike. Analysts say the july rate hike ...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
The House advances a sweeping housing bill described as the first major housing since the 1990s, signaling a national...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
Software stocks are rebounding as growth signals improve and enterprise demand remains resilient. Analysts warn that ...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Goldman Sachs foresees a trillion-dollar space economy within the next two decades, underpinned by commercial growth ...